From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
The largest pharmacy-benefit managers hiked the prices of dozens of drugs dispensed through their own pharmacies, according ...
A bipartisan, bicameral group of lawmakers is calling on the Federal Trade Commission (FTC) to vote in favor of releasing an ...
The FTC claims that the prices of some specialty drugs used to treat conditions such as cancer or HIV are being marked up as much as 1,000%.
A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
Pharmacy benefit managers make decisions about medication access that aren’t always based on the best interests of patients.
A new FTC report blames Pharmacy Benefit Managers for marking up specialty drug prices, profiting $7.3 billion from cancer and HIV treatments between 2017-2022.
Apparently, it does not end with them. The fallout radius of the Blake Lively and Justin Baldoni legal battle continues to ...
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...